Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
about
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideUse of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.Variability in medical marijuana laws in the United States.Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
P2860
Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
@ast
Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
@en
type
label
Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
@ast
Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
@en
prefLabel
Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
@ast
Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
@en
P2860
P356
P1476
Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.
@en
P2093
S E Straus
P2860
P304
P356
10.1073/PNAS.180314297
P407
P577
2000-08-01T00:00:00Z